Shanghai No 1 Pharmacy Co (SHSE:600833) Stock Based Compensation: ¥0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600833 Shanghai No 1 Pharmacy Co Ltd SHSE:600833
58 GF Score
Price ¥11.70
GF Value ¥12.77
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai No 1 Pharmacy Co Stock Based Compensation?

Shanghai No 1 Pharmacy Co SHSE:600833 -1.52% 58 Stock Based Compensation is ¥0 Mil as of Mar. 2026. GuruFocus rates SHSE:600833 with a GF Score™ of 58/100 and a GF Value™ of ¥12.77 (Fairly Valued). The stock has 6 warning signs investors should review.

Shanghai No 1 Pharmacy Co's Stock Based Compensation for the three months ended in Mar. 2026 was ¥0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0 Mil.

Shanghai No 1 Pharmacy Co Stock Based Compensation Related Terms

Shanghai No 1 Pharmacy Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Shanghai No 1 Pharmacy Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai No 1 Pharmacy Co Stock Based Compensation Chart

Shanghai No 1 Pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shanghai No 1 Pharmacy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:600833
58GF Score
Shanghai No 1 Pharmacy Co Ltd SHSE:600833
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai No 1 Pharmacy Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

What does a Stock Based Compensation of ¥0 Mil mean?
Shanghai No 1 Pharmacy Co (SHSE:600833) has a Stock Based Compensation of ¥0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Shanghai No 1 Pharmacy Co and its competitors.
Is Shanghai No 1 Pharmacy Co's Stock Based Compensation too high?
Shanghai No 1 Pharmacy Co's current Stock Based Compensation is ¥0 Mil. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's Stock Based Compensation compare to competitors?
Shanghai No 1 Pharmacy Co's Stock Based Compensation of ¥0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Shanghai No 1 Pharmacy Co and its competitors. Shanghai No 1 Pharmacy Co's current Stock Based Compensation is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Fairly Valued. The stock's GF Value™ is ¥12.77, compared to a current price of ¥11.70 — trading 8.4% below its estimated fair value. The current Stock Based Compensation is ¥0 Mil. Shanghai No 1 Pharmacy Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current Stock Based Compensation is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued. The current stock price of ¥11.70 is trading 8.4% below its estimated GF Value™ of ¥12.77. GuruFocus considers Shanghai No 1 Pharmacy Co to be Fairly Valued.

Key valuation signals for SHSE:600833:

  • Stock Based Compensation: ¥0 Mil
  • GF Value™: ¥12.77 vs. price of ¥11.70 (8.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai No 1 Pharmacy Co Business Description

Address No. 616 Nanjing East Road, Huangpu District, Shanghai, CHN, 200032
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
58GF Score

Get the complete analysis for SHSE:600833

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.70
Price
¥12.77
GF Value